The presence of microvascular invasion guides treatment strategy in recurrent HBV-related HCC-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The presence of microvascular invasion guides treatment strategy in recurrent HBV-related HCC

Published:2020-02-11 Issue:6 Volume:30 Page:3473-3485
ISSN:0938-7994
Container-title:European Radiology
language:en
Short-container-title:Eur Radiol

Author:

Chen Shu-Ling,Xiao Han,Xie Zong-Lin,Shen Jing-Xian,Chen Ze-Bin,Wang Yuan-Qi,Li Bin,Peng Zhen-Wei,Kuang Ming,Lai Jia-Ming,Peng Sui

Funder

National Natural Science Foundation of China

National Science Fund for Distinguished Young Scholars

Natural Science Foundation of Guangdong Province

National high level talents special support plan--Ten thousand plan--Young top-notch talent support program

Kelin Outstanding Young Scientist of the First Affiliated Hospital of Sun Yet-sen University

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00330-019-06640-8.pdf

Reference34 articles.

1. Koh PS, Chan ACY, Cheung TT et al (2016) Efficacy of radiofrequency ablation compared with transarterial chemoembolization for the treatment of recurrent hepatocellular carcinoma: a comparative survival analysis. HPB (Oxford) 18:72–78. https://doi.org/10.1016/j.hpb.2015.07.005

2. Dai WC, Cheung TT (2016) Strategic overview on the best treatment option for intrahepaitc hepatocellular carcinoma recurrence. Expert Rev Anticancer Ther 16:1063–1072. https://doi.org/10.1080/14737140.2016.1226136

3. Joliat G-R, Allemann P, Labgaa I et al (2017) Treatment and outcomes of recurrent hepatocellular carcinomas. Langenbecks Arch Surg 402:1–8. https://doi.org/10.1007/s00423-017-1582-9

4. Imamura H, Matsuyama Y, Tanaka E et al (2003) Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 38:200–207

5. Tung-Ping Poon R, Fan ST, Wong J (2000) Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 232:10–24. https://doi.org/10.1097/00000658-200007000-00003

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Threatment Strategies for Recurrent Hepatocellular Carcinoma Patients: Ablation and its Combination Patterns;Journal of Cancer;2024

2. Management of early-stage hepatocellular carcinoma: challenges and strategies for optimal outcomes;Journal of Liver Cancer;2023-09-30

3. Predicting Outcome after Percutaneous Ablation for Early-Stage Hepatocellular Carcinoma Using Various Imaging Modalities;Diagnostics;2023-09-26

4. Perioperative predictors of outcome of hepatectomy for HBV-related hepatocellular carcinoma;Frontiers in Oncology;2023-07-13

5. A Nomogram Based on Contrast-Enhanced Ultrasound to Predict the Microvascular Invasion in Hepatocellular Carcinoma;Ultrasound in Medicine & Biology;2023-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3